Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSafety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
Blood, 05/29/09
Richardson P et al. - Lenalidomide monotherapy has acceptable toxicities and is active in relapsed and refractory MM patients. These data support treatment with single-agent lenalidomide, as well as its use in steroid-sparing combination approaches.
Related Articles
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry
Acta Haematologica, 11/04/09
Relevance Score: 89%
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Journal of Clinical Oncology, 10/02/09
Relevance Score: 89%
Characteristics of Orbital Multiple Myeloma: A Case Report and Literature Review
Survey of Ophthalmology, 10/23/09
Relevance Score: 88%
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Leukemia, 10/05/09
Relevance Score: 88%
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 87%
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Solitary Plasmacytoma
American Journal of Clinical Oncology, 12/08/09
Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/08/09
Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/08/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09
Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Haematologica, 12/08/09
New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09
Sponsor
Article Search
Sponsor
Sponsor